Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Switching high efficacy therapies in Multiple Sclerosis: Does real world experience support such a strategy?
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 05, 2025
Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system.
Journal: International immunopharmacology
Published: August 22, 2025
The mechanism of disease progression by aging and age-related gut dysbiosis in multiple sclerosis.
Journal: Neurobiology of disease
Published: February 14, 2025
Alternative Splicing in Multiple Sclerosis: A Promising Biomarker of Therapeutic Response to Interferon-β.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: May 27, 2024
Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Journal: International journal of molecular sciences
Published: August 31, 2023
Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis.
Journal: Frontiers in immunology
Published: August 09, 2022
Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity.
Journal: The Journal of international medical research
Published: February 04, 2022
Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: April 18, 2021
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 11, 2021
Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition.
Journal: Journal of clinical medicine
Published: December 23, 2020
Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein.
Journal: Microorganisms
Published: November 26, 2020
Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
Journal: Investigative radiology
Published: September 08, 2020
Last Updated: 09/26/2026